IO Biotech, Inc. (IOBT)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
IOBT Insider Trading Activity
IOBT Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $54,876 | 4 | 57 |
Sells | $901,621 | 3 | 43 |
Related Transactions
| Ahmad Qasim Iftikhar | Chief Medical Officer | 1 | $26,553 | 0 | $0 | $26,553 |
| Zocca Mai-Britt | Chief Executive Officer | 1 | $10,120 | 0 | $0 | $10,120 |
| Smith Devin Whittemore | General Counsel | 1 | $9,720 | 0 | $0 | $9,720 |
| Sullivan Amy | Chief Financial Officer | 1 | $8,483 | 0 | $0 | $8,483 |
| Novo Holdings A/S | 10 percent owner | 0 | $0 | 3 | $901,621 | $-901,621 |
About IO Biotech, Inc.
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single …
Insider Activity of IO Biotech, Inc.
Over the last 12 months, insiders at IO Biotech, Inc. have bought $54,876 and sold $901,621 worth of IO Biotech, Inc. stock.
On average, over the past 5 years, insiders at IO Biotech, Inc. have bought $24.67M and sold $945,016 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ahmad Qasim Iftikhar (Chief Medical Officer) — $26,553. Zocca Mai-Britt (Chief Executive Officer) — $10,120. Smith Devin Whittemore (General Counsel) — $9,720.
The last purchase of 10,250 shares for transaction amount of $8,483 was made by Sullivan Amy (Chief Financial Officer) on 2024‑12‑23.
List of Insider Buy and Sell Transactions, IO Biotech, Inc.
| 2024-12-23 | Sullivan Amy | Chief Financial Officer | 10,250 0.0148% | $0.83 | $8,483 | +3.56% | ||
| 2024-12-23 | Zocca Mai-Britt | Chief Executive Officer | 12,500 0.0177% | $0.81 | $10,120 | +3.56% | ||
| 2024-12-23 | Ahmad Qasim Iftikhar | Chief Medical Officer | 31,350 0.0463% | $0.85 | $26,553 | +3.56% | ||
| 2024-12-23 | Smith Devin Whittemore | General Counsel | 12,000 0.017% | $0.81 | $9,720 | +3.56% | ||
| 2024-07-26 | Sale | Novo Holdings A/S | 10 percent owner | 23,478 0.0362% | $1.31 | $30,787 | -26.12% | |
| 2024-07-25 | Sale | Novo Holdings A/S | 10 percent owner | 51,522 0.0774% | $1.33 | $68,339 | -28.66% | |
| 2024-05-10 | Sale | Novo Holdings A/S | 10 percent owner | 658,809 0.8518% | $1.22 | $802,495 | -23.78% | |
| 2024-02-09 | Sale | Novo Holdings A/S | 10 percent owner | 658,809 0.8023% | $1.50 | $988,411 | -23.93% | |
| 2023-11-22 | Burkavage Brian | Chief Accounting Officer | 5,000 0.0076% | $1.03 | $5,175 | +31.43% | ||
| 2023-11-21 | Burkavage Brian | Chief Accounting Officer | 5,000 0.0074% | $0.99 | $4,950 | +36.63% | ||
| 2023-08-09 | Novo Holdings A/S | 10 percent owner | 2.47M 9.534% | $2.02 | $5M | -19.17% | ||
| 2023-08-09 | Vivo Capital IX, LLC | 10 percent owner | 3.16M 11.4408% | $1.90 | $6M | -19.17% | ||
| 2023-03-17 | Sullivan Amy | Chief Financial Officer | 25,000 0.1017% | $2.32 | $58,018 | -8.08% | ||
| 2021-11-09 | Lundbeckfond Invest A/S | 10 percent owner | 2.14M 51.9475% | $14.00 | $30M | -62.27% | ||
| 2021-11-09 | Novo Holdings A/S | 10 percent owner | 325,000 7.8787% | $14.00 | $4.55M | -62.27% | ||
| 2021-11-09 | Vivo Capital IX, LLC | 10 percent owner | 650,000 15.7574% | $14.00 | $9.1M | -62.27% | ||
| 2021-11-09 | Nielsen Jack | director | 650,000 15.7574% | $14.00 | $9.1M | -62.27% | ||
| 2021-11-09 | HBM Healthcare Investments (Cayman) Ltd. | 10 percent owner | 325,000 7.8787% | $14.00 | $4.55M | -62.27% | ||
| 2021-11-09 | Andersson Claus A. | director | 75,000 1.8182% | $14.00 | $1.05M | -62.27% | ||
| 2021-11-09 | Malier Vanessa | director | 325,000 7.8787% | $14.00 | $4.55M | -62.27% |
Insider Historical Profitability
| Novo Holdings A/S | 10 percent owner | 4354449 6.6096% | $3.83M | 2 | 4 | <0.0001% |
| Sullivan Amy | Chief Financial Officer | 84632 0.1285% | $74,374.60 | 2 | 0 | <0.0001% |
| Zocca Mai-Britt | Chief Executive Officer | 49891 0.0757% | $43,844.21 | 1 | 0 | |
| Ahmad Qasim Iftikhar | Chief Medical Officer | 31350 0.0476% | $27,550.38 | 1 | 0 | |
| Smith Devin Whittemore | General Counsel | 16938 0.0257% | $14,885.11 | 1 | 0 |
Historical Insider Profitability vs. Competitors
$6,787,959 | 35 | 49.84% | $60.62M | |
$459,011,221 | 33 | 33.04% | $57.94M | |
$144,247,213 | 29 | 10.15% | $64.24M | |
$2,239,226 | 28 | 3.41% | $63.36M | |
$26,736,140 | 20 | -18.64% | $54.85M |
IOBT Institutional Investors: Active Positions
| Increased Positions | 12 | +44.44% | 2M | +7.23% |
| Decreased Positions | 9 | -33.33% | 6M | -23.84% |
| New Positions | 11 | New | 2M | New |
| Sold Out Positions | 5 | Sold Out | 4M | Sold Out |
| Total Postitions | 30 | +11.11% | 20M | -16.61% |
IOBT Ownership Change vs Market
Institutional Investor Ownership
| Vivo Capital, Llc | $5,834.00 | 9.35% | 6.17M | 0 | 0% | 2024-12-31 |
| Novo Holdings A/S | $3,170.00 | 5.08% | 3.35M | 0 | 0% | 2024-12-31 |
| Pfm Health Sciences, Lp | $2,212.00 | 3.55% | 2.34M | 0 | 0% | 2024-12-31 |
| Marshall Wace, Llp | $1,989.00 | 3.19% | 2.11M | 0 | 0% | 2024-12-31 |
| Bank Of America Corp /De/ | $1,561.00 | 2.5% | 1.65M | 0 | 0% | 2024-12-31 |
| Pivotal Bioventure Partners Investment Advisor Llc | $817.00 | 1.31% | 864,197 | 0 | 0% | 2024-12-31 |
| Morgan Stanley | $812.00 | 1.3% | 859,175 | -1M | -60.98% | 2024-12-31 |
| Dauntless Investment Group, Llc | $707.00 | 1.13% | 747,646 | +747,646 | New | 2024-12-31 |
| Landscape Capital Management, L.L.C. | $418.00 | 0.67% | 442,196 | +442,196 | New | 2024-12-31 |
| Citadel Advisors Llc | $256.00 | 0.41% | 270,504 | +270,504 | New | 2024-12-31 |